At a glance
ClinicalIndex Comparison RecordN/ACompleted· 148 enrolled
Drug / intervention
No Interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Phenotyping and Genotyping of HIV-Associated Sensory Neuropathy: The HIV-POGO Study
In Brief
An observational study evaluating No Intervention for HIV and 2 related conditions. Completed, enrolled 148 participants across 1 site.
Detailed Summary
This study aims to recruit a cohort of HIV patients with and without HIV-SN and to identify genetic risk factors for the development of HIV-SN and neuropathic pain. It also aims to more deeply phenotype the condition, using well validated questionnaires, and to identify any influence that early neurocognitive dysfunction may have on the reporting, diagnosis and treatment of neuropathic pain in the HIV population.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHIV, Sensory Neuropathy, Neuropathic Pain
CountriesUnited Kingdom
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartDec 2014
First PostedSep 2015
Primary CompletionJan 2019
TodayJul 2026
First PostedSep 22, 2015
Enrollment StartDec 1, 2014
Primary CompletionJan 1, 2019
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 10.8 years ago
Interventions
No Interventionother
No intervention - observational only